These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11876716)
1. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. De Schryver AM; Andriesse GI; Samsom M; Smout AJ; Gooszen HG; Akkermans LM Aliment Pharmacol Ther; 2002 Mar; 16(3):603-12. PubMed ID: 11876716 [TBL] [Abstract][Full Text] [Related]
2. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Sloots CE; Poen AC; Kerstens R; Stevens M; De Pauw M; Van Oene JC; Meuwissen SG; Felt-Bersma RJ Aliment Pharmacol Ther; 2002 Apr; 16(4):759-67. PubMed ID: 11929394 [TBL] [Abstract][Full Text] [Related]
3. Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers. Clemens CH; Samsom M; Van Berge Henegouwen GP; Fabri M; Smout AJ Aliment Pharmacol Ther; 2002 May; 16(5):993-1002. PubMed ID: 11966509 [TBL] [Abstract][Full Text] [Related]
4. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study. Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968 [TBL] [Abstract][Full Text] [Related]
5. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Bouras EP; Camilleri M; Burton DD; McKinzie S Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205 [TBL] [Abstract][Full Text] [Related]
6. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation. Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679 [TBL] [Abstract][Full Text] [Related]
7. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Poen AC; Felt-Bersma RJ; Van Dongen PA; Meuwissen SG Aliment Pharmacol Ther; 1999 Nov; 13(11):1493-7. PubMed ID: 10571606 [TBL] [Abstract][Full Text] [Related]
8. High-resolution manometry reveals different effect of polyethylene glycol, bisacodyl, and prucalopride on colonic motility in healthy subjects: An acute, open label, randomized, crossover, reader-blinded study with potential clinical implications. Corsetti M; Thys A; Harris A; Pagliaro G; Deloose E; Demedts I; Tack J Neurogastroenterol Motil; 2021 May; 33(5):e14040. PubMed ID: 33301221 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834 [TBL] [Abstract][Full Text] [Related]
10. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586 [TBL] [Abstract][Full Text] [Related]
11. Effects and sites of action of a M1 receptor positive allosteric modulator on colonic motility in rats and dogs compared with 5-HT Tsukimi Y; Pustovit RV; Harrington AM; Garcia-Caraballo S; Brierley SM; Di Natale M; Molero JC; Furness JB Neurogastroenterol Motil; 2020 Aug; 32(8):e13866. PubMed ID: 32337809 [TBL] [Abstract][Full Text] [Related]
12. Oral prucalopride in children with functional constipation. Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761 [TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery. Gong J; Xie Z; Zhang T; Gu L; Yao W; Guo Z; Li Y; Lu N; Zhu W; Li N; Li J Aliment Pharmacol Ther; 2016 Apr; 43(7):778-89. PubMed ID: 26880227 [TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled trial of prucalopride for severe chronic constipation. Camilleri M; Kerstens R; Rykx A; Vandeplassche L N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121 [TBL] [Abstract][Full Text] [Related]